Verrica Pharmaceuticals Announces Launch of YCANTH® for the Treatment of Molluscum Contagiosum in Japan by Partner Torii Pharmaceutical
Verrica Pharmaceuticals (NASDAQ:VRCA) was downgraded by analysts at
Wall
Verrica Pharmaceuticals (NASDAQ:VRCA) was upgraded by analysts at
Wall S
Verrica Pharmaceuticals (NASDAQ:VRCA) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
Verrica Pharmaceuticals (NASDAQ:VRCA) had its "buy" rating reaffirmed by analysts at Cowen Inc.